866-997-4948(US-Canada Toll Free)

China Human Respiratory Syncytial Virus Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

Notes:
Sales, means the sales volume of Human Respiratory Syncytial Virus Drugs
Revenue, means the sales value of Human Respiratory Syncytial Virus Drugs

This report studies Human Respiratory Syncytial Virus Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
AstraZeneca
AbbVie
GSK
Teva Pharmaceutical
Ablynx
ADMA Biologics
Alnylam Pharmaceuticals
Ark Biosciences
Aviragen Therapeutics
Bavarian Nordic
Boehringer Ingelheim
Gilead Sciences
ImmunoVaccine Technologies
Johnson & Johnson
Kyowa Hakko Kirin
Medivir, Mucosis
Mymetics
Novavax
Regeneron Pharmaceuticals
ReViral
Vaxart

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Approved Drugs
Off-Label Drugs
Split by Application, this report focuses on consumption, market share and growth rate of Human Respiratory Syncytial Virus Drugs in each application, can be divided into
Hospitals
Clinics

Table of Contents

China Human Respiratory Syncytial Virus Drugs Market Research Report 2017
1 Human Respiratory Syncytial Virus Drugs Market Overview
1.1 Product Overview and Scope of Human Respiratory Syncytial Virus Drugs
1.2 Human Respiratory Syncytial Virus Drugs Segment by Type
1.2.1 China Production Market Share of Human Respiratory Syncytial Virus Drugs Type in 2015
1.2.2 Approved Drugs
1.2.3 Off-Label Drugs
1.3 Applications of Human Respiratory Syncytial Virus Drugs
1.3.1 Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
1.3.2 Hospitals
1.3.3 Clinics
1.4 China Market Size (Value) of Human Respiratory Syncytial Virus Drugs (2012-2022)
1.5 China Human Respiratory Syncytial Virus Drugs Status and Outlook
1.6 Government Policies

2 China Human Respiratory Syncytial Virus Drugs Market Competition by Manufacturers
2.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Human Respiratory Syncytial Virus Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Human Respiratory Syncytial Virus Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Respiratory Syncytial Virus Drugs Market Competitive Situation and Trends
2.5.1 Human Respiratory Syncytial Virus Drugs Market Concentration Rate
2.5.2 Human Respiratory Syncytial Virus Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Human Respiratory Syncytial Virus Drugs Manufacturers Profiles/Analysis
3.1 AstraZeneca
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 AbbVie
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 GSK
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Teva Pharmaceutical
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Ablynx
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 ADMA Biologics
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Alnylam Pharmaceuticals
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Ark Biosciences
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Aviragen Therapeutics
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Bavarian Nordic
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Boehringer Ingelheim
3.12 Gilead Sciences
3.13 ImmunoVaccine Technologies
3.14 Johnson & Johnson
3.15 Kyowa Hakko Kirin
3.16 Medivir, Mucosis
3.17 Mymetics
3.18 Novavax
3.19 Regeneron Pharmaceuticals
3.20 ReViral
3.21 Vaxart

4 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)
4.2 China Human Respiratory Syncytial Virus Drugs Revenue and Growth (2012-2017)
4.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

5 China Human Respiratory Syncytial Virus Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Type (2012-2017)
5.2 China Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)
5.4 China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)

6 China Human Respiratory Syncytial Virus Drugs Market Analysis by Application
6.1 China Human Respiratory Syncytial Virus Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaHuman Respiratory Syncytial Virus Drugs Market Analysis by Regions (Provinces)
7.1 China Human Respiratory Syncytial Virus Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Human Respiratory Syncytial Virus Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

8 Human Respiratory Syncytial Virus Drugs Manufacturing Cost Analysis
8.1 Human Respiratory Syncytial Virus Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Human Respiratory Syncytial Virus Drugs Market Forecast (2017-2022)
12.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)
12.4 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)
12.5 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Human Respiratory Syncytial Virus Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Human Respiratory Syncytial Virus Drugs
Figure China Production Market Share of Human Respiratory Syncytial Virus Drugs by Type in 2015
Figure Product Picture of Approved Drugs
Table Major Manufacturers of Approved Drugs
Figure Product Picture of Off-Label Drugs
Table Major Manufacturers of Off-Label Drugs
Table Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Human Respiratory Syncytial Virus Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2015
Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2016
Table China Human Respiratory Syncytial Virus Drugs Production of Key Manufacturers (2015 and 2016)
Table China Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers
Figure 2016 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers
Table China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
Table 2016 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers
Table China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Respiratory Syncytial Virus Drugs Product Type
Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 3 Manufacturers
Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 5 Manufacturers
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Ablynx Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Ablynx Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure ADMA Biologics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Ark Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Ark Biosciences Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Aviragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bavarian Nordic Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ImmunoVaccine Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medivir, Mucosis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mymetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ReViral Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)
Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production by Type (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Human Respiratory Syncytial Virus Drugs by Type
Table China Human Respiratory Syncytial Virus Drugs Revenue by Type (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Human Respiratory Syncytial Virus Drugs by Type
Table China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)
Figure China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Consumption by Application (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application (2012-2017)
Figure China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015
Table China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Respiratory Syncytial Virus Drugs
Figure Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs
Figure Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis
Table Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015
Table Major Buyers of Human Respiratory Syncytial Virus Drugs
Table Distributors/Traders List
Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *